Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Tongqiao Jingxuan granules for residual dizziness after successful repositioning in benign paroxysmal positional vertigo
CTR20254385Phase 2Active
- Sponsor
- Jiuhua Huayuan Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tongqiao Jingxuan Granules in benign paroxysmal positional vertigo (BPPV), sponsored by Jiuhua Huayuan Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
Tongqiao Jingxuan Granules
03
Conditions
benign paroxysmal positional vertigo (BPPV)
Beyond the preview
Go deeper on CTR20254385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254385.